Cargando…
Coating (Coating to Optimize Aneurysm Treatment in the New Flow Diverter Generation) study. The first randomized controlled trial evaluating a coated flow diverter (p64 MW HPC): study design
BACKGROUND: Due to its high efficacy, flow diversion is increasingly used in the management of unruptured and recanalized aneurysms. Because of the need for perioperative dual antiplatelet treatment (DAPT), flow diversion is not indicated for the treatment of ruptured aneurysms. To overcome this maj...
Autores principales: | Pierot, Laurent, Lamin, Saleh, Barreau, Xavier, Berlis, Ansgar, Ciceri, Elisa, Cohen, José E, Costalat, Vincent, Eker, Omer F, Henkes, Hans, Holtmannspötter, Markus, Januel, Anne-Christine, Keston, Peter, Klisch, Joachim, Psychogios, Marios-Nikos, Valvassori, Luca, Cognard, Christophe, Spelle, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314041/ https://www.ncbi.nlm.nih.gov/pubmed/35609974 http://dx.doi.org/10.1136/neurintsurg-2022-018969 |
Ejemplares similares
-
Coated Flow Diverters and Single Antiplatelet Treatment: Where are We?
por: Pierot, Laurent
Publicado: (2022) -
Comparison of the Thrombogenicity of a Bare and Antithrombogenic Coated Flow Diverter in an In Vitro Flow Model
por: Lenz-Habijan, T., et al.
Publicado: (2019) -
Prospective study to assess the tissue response to HPC-coated p48 flow diverter stents compared to uncoated devices in the rabbit carotid artery model
por: Lenz-Habijan, Tim, et al.
Publicado: (2019) -
Vascular Response on a Novel Fibrin-Based Coated Flow Diverter
por: Mühl-Benninghaus, Ruben, et al.
Publicado: (2021) -
Early clinical experience with the p48MW HPC and p64MW HPC flow
diverters in the anterior circulation aneurysm using single anti-platelet
treatment
por: Bhogal, Pervinder, et al.
Publicado: (2021)